Cancer Cachexia

Area of Science:

• Muscle physiology and metabolism
• Oncology and cancer biology
• Disease-related wasting syndromes

Background:

• Skeletal muscle is vital for adult health, physical function, and quality of life.
• Muscle mass and metabolic quality are critical, especially in aging and chronic diseases.
• Cancer-induced cachexia, an involuntary loss of muscle and fat, increases mortality and morbidity in cancer patients.

Purpose of the Study:

• To investigate the impact of cancer and its treatment on skeletal muscle mass, function, and metabolic quality.
• To explore systemic mediators and metabolic crosstalk driving cancer-induced wasting.
• To examine factors like sex, physical activity, chemotherapy, and cancer type influencing muscle wasting.

Main Methods:

• Review of current understanding of cancer's effects on skeletal muscle.
• Exploration of systemic mediators and inter-tissue metabolic crosstalk.
• Discussion of modulating factors including sex, physical activity, and chemotherapy.

Main Results:

• Cancer and its treatments significantly degrade skeletal muscle mass, function, and metabolic properties.
• Systemic factors and metabolic crosstalk between tissues are key drivers of muscle wasting.
• Individual factors like sex, physical activity, and chemotherapy regimens influence the severity of muscle loss.

Conclusions:

• There is a critical need to understand how preserving muscle function and metabolic health improves cancer patient survival.
• Current therapeutic options for preventing or reversing cancer-induced muscle loss are limited.
• Further research into the mechanisms of cancer-induced muscle wasting is essential for developing effective interventions.